BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7902680)

  • 1. Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice.
    Holmes BB; Fujimoto JM
    Anesth Analg; 1993 Dec; 77(6):1166-73. PubMed ID: 7902680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
    Rady JJ; Fujimoto JM
    Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
    Holmes BB; Fujimoto JM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
    Rady JJ; Holmes BB; Fujimoto JM
    Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
    Aksu F; Holmes BB; Fujimoto JM
    Pharmacol Biochem Behav; 1993 Jun; 45(2):409-18. PubMed ID: 8101007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous dynorphin modulates calcium-mediated antinociception in mice.
    Smith FL; Dewey WL
    Pharmacol Biochem Behav; 1993 Jun; 45(2):383-91. PubMed ID: 8101006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
    Wang FS; Fujimoto JM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
    Arts KS; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin.
    Arts KS; Fujimoto JM; Crain SM
    Pharmacol Biochem Behav; 1993 Nov; 46(3):623-9. PubMed ID: 7904072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17).
    Fujimoto JM; Arts KS
    Neuropharmacology; 1990 Apr; 29(4):351-8. PubMed ID: 1971432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
    Fujimoto JM; Rady JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
    Rady JJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism by nalmefene of systemic and intrathecal morphine-induced analgesia in mice.
    Roerig SC; Arteau C; Fujimoto JM
    Proc Soc Exp Biol Med; 1987 Nov; 186(2):234-9. PubMed ID: 3671362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
    Fujimoto JM; Holmes B
    J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
    Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
    Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.